We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.42B
AUM Growth
+$53.3M
(+3.9%)
Cap. Flow
+$29.9M
Cap. Flow
% of AUM
2.1%
Top 10 Holdings %
Top 10 Hldgs %
26.02%
Holding
276
New
21
Increased
128
Reduced
73
Closed
13
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.96M |
| 2 |
Merck
MRK
|
+$6.29M |
| 3 |
UnitedHealth
UNH
|
+$5.85M |
| 4 |
Amazon
AMZN
|
+$5.11M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$11.9M |
| 2 |
Cardinal Health
CAH
|
+$9.07M |
| 3 |
AT&T
T
|
+$3.98M |
| 4 |
Medtronic
MDT
|
+$3.36M |
| 5 |
Estee Lauder
EL
|
+$2.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.84% |
| 2 | Healthcare | 14.41% |
| 3 | Technology | 13.82% |
| 4 | Industrials | 11.14% |
| 5 | Energy | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Amgen
AMGN
$235B
| $685K | 0.05% |
4,680
+709
| +18% | +$107K |
2013 Q3
13 quarters
|
|
152
Tennant Co
TNC
$1.12B
| $679K | 0.05% |
9,540
-99
| -1% | -$6.82K |
2016 Q1
3 quarters
|
|
153
Invesco MSCI Sustainable Future ETF
ERTH
$120M
| $673K | 0.05% |
20,588
+11,087
| +117% | +$359K |
2015 Q2
6 quarters
|
|
154
DELISTED
Anadarko Petroleum
APC
| $669K | 0.05% |
9,596
-378
| -4% | -$24.6K |
2013 Q2
14 quarters
|
|
155
Simon Property Group
SPG
$65.8B
| $668K | 0.05% |
3,760
| – | – |
2016 Q2
2 quarters
|
|
|
IMPV
156
DELISTED
Imperva, Inc.
IMPV
| $646K | 0.05% |
16,835
+291
| +2% | +$11.8K |
2016 Q2
2 quarters
|
|
157
Philip Morris
PM
$312B
| $635K | 0.04% |
6,945
+950
| +16% | +$88K |
2013 Q2
14 quarters
|
|
158
Pool Corp
POOL
$6.15B
| $634K | 0.04% |
6,076
+188
| +3% | +$18.6K |
2016 Q1
3 quarters
|
|
159
iShares MSCI Emerging Markets ETF
EEM
$29.6B
| $626K | 0.04% |
17,882
-691
| -4% | -$24.9K |
2013 Q2
14 quarters
|
|
160
Charles Schwab
SCHW
$163B
| $623K | 0.04% |
15,794
+53
| +0.3% | +$1.89K |
2016 Q1
3 quarters
|
|
161
Bank of America
BAC
$362B
| $613K | 0.04% |
27,732
-5,006
| -15% | -$96.4K |
2013 Q2
14 quarters
|
|
162
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
| $610K | 0.04% |
+9,806
| New | +$591K |
2016 Q4
0 quarters
|
|
163
Diageo
DEO
$52.2B
| $605K | 0.04% |
5,825
-80
| -1% | -$8.42K |
2016 Q2
2 quarters
|
|
164
iShares MSCI Pacific ex Japan ETF
EPP
$2.21B
| $600K | 0.04% |
15,170
-350
| -2% | -$14.4K |
2013 Q2
14 quarters
|
|
165
iShares Russell 2000 Value ETF
IWN
$13.8B
| $600K | 0.04% |
5,047
+83
| +2% | +$9.17K |
2016 Q2
2 quarters
|
|
|
CALD
166
DELISTED
Callidus Software, Inc.
CALD
| $595K | 0.04% |
35,398
+1,637
| +5% | +$27.9K |
2015 Q2
6 quarters
|
|
167
Target
TGT
$71.2B
| $594K | 0.04% |
8,225
| – | – |
2013 Q2
14 quarters
|
|
168
American Tower
AMT
$84.5B
| $584K | 0.04% |
5,524
+276
| +5% | +$30K |
2016 Q2
2 quarters
|
|
169
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $583K | 0.04% |
18,176
| – | – |
2013 Q2
14 quarters
|
|
170
DELISTED
Kellanova
K
| $582K | 0.04% |
8,414
| – | – |
2013 Q2
14 quarters
|
|
|
FRC
171
DELISTED
First Republic Bank
FRC
| $576K | 0.04% |
6,251
+932
| +18% | +$76.1K |
2015 Q2
6 quarters
|
|
172
Yum! Brands
YUM
$41.2B
| $571K | 0.04% |
9,024
-3,807
| -30% | -$239K |
2013 Q2
14 quarters
|
|
173
Altria Group
MO
$123B
| $560K | 0.04% |
8,285
+1,100
| +15% | +$70.8K |
2013 Q2
14 quarters
|
|
174
Mondelez International
MDLZ
$80.4B
| $555K | 0.04% |
12,530
+784
| +7% | +$33.8K |
2014 Q4
8 quarters
|
|
175
PPG Industries
PPG
$24B
| $545K | 0.04% |
5,743
+16
| +0.3% | +$1.53K |
2013 Q2
14 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q4 2016 Portfolio in Review
As of Q4 2016, Cambridge Trust held 276 positions worth $1.42B, up 3.9% from $1.37B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cambridge Trust's Q4 2016 filing shows 21 new, 128 increased, 73 reduced and 13 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M. The largest sale was Novartis, an estimated $11.9M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Cambridge Trust's largest Q4 2016 buy was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M.
- Cambridge Trust added most to Celgene Corp in Q4 2016, an estimated $6.96M increase.
- Cambridge Trust's biggest Q4 2016 reduction was Novartis, cutting an estimated $11.9M.
- Cambridge Trust fully exited Cardinal Health in Q4 2016, selling an estimated $9.07M.
- Cambridge Trust's ten largest holdings make up 26% of its $1.42B portfolio in Q4 2016.
- Cambridge Trust opened 21 new positions and closed 13 in Q4 2016.
- Cambridge Trust's portfolio value rose 3.9% quarter-over-quarter to $1.42B.
Based on Cambridge Trust's 13F filing for Q4 2016, filed 3 Feb 2017.